Nugen Medical Devices Stock Fundamentals
| NGMDF Stock | USD 0.03 0.00 0.00% |
Fundamental analysis of NuGen Medical allows traders to better anticipate movements in NuGen Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
NuGen |
NuGen Medical Devices OTC Stock Return On Equity Analysis
NuGen Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NuGen Medical Return On Equity | -14.72 |
Most of NuGen Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuGen Medical Devices is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, NuGen Medical Devices has a Return On Equity of -14.7202. This is 38.59% lower than that of the Healthcare sector and 68.62% higher than that of the Medical Devices industry. The return on equity for all United States stocks is notably higher than that of the company.
NuGen Medical Devices Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuGen Medical's current stock value. Our valuation model uses many indicators to compare NuGen Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuGen Medical competition to find correlations between indicators driving NuGen Medical's intrinsic value. More Info.NuGen Medical Devices is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuGen Medical's earnings, one of the primary drivers of an investment's value.NuGen Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuGen Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of NuGen Medical could also be used in its relative valuation, which is a method of valuing NuGen Medical by comparing valuation metrics of similar companies.NuGen Medical is currently under evaluation in return on equity category among its peers.
NuGen Fundamentals
| Return On Equity | -14.72 | |||
| Return On Asset | -0.42 | |||
| Operating Margin | (29.06) % | |||
| Current Valuation | 7.67 M | |||
| Shares Outstanding | 96.56 M | |||
| Shares Owned By Insiders | 19.15 % | |||
| Price To Book | 9.94 X | |||
| Price To Sales | 13.04 X | |||
| Revenue | 137.65 K | |||
| Gross Profit | 47.3 K | |||
| EBITDA | (5.09 M) | |||
| Net Income | (7.11 M) | |||
| Cash And Equivalents | 87.48 K | |||
| Total Debt | 5.61 M | |||
| Debt To Equity | 7.40 % | |||
| Current Ratio | 0.45 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (4.1 M) | |||
| Earnings Per Share | (0.08) X | |||
| Market Capitalization | 5.74 M | |||
| Total Asset | 8.84 M | |||
| Z Score | 0.6 | |||
| Net Asset | 8.84 M |
About NuGen Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NuGen Medical Devices's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuGen Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuGen Medical Devices based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventionalpediatric vaccines. Nugen Med operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in NuGen OTC Stock
NuGen Medical financial ratios help investors to determine whether NuGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGen with respect to the benefits of owning NuGen Medical security.